32 results on '"Karampeazis, Athanasios"'
Search Results
2. Efficacy of panitumumab in older patients with metastatic colorectal cancer: a retrospective analysis using the database of the Hellenic Oncology Research Group (HORG)
3. Exploring the Use of a Digital Platform for Cancer Patients to Report Their Demographics, Disease and Therapy Characteristics, Age, and Educational Disparities: An Early-Stage Feasibility Study
4. Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: Lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III study
5. Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non–Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group
6. Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review
7. Assessment and Impact of Comorbidity in Older Adults with Cancer
8. CureCancer Digital Platform in Clinical Oncology Practice Facilitates Patients’ Self-data Recording, Communicating, Treatment Adherence, “Distancing Interventions” During Covid-19 and Reduces Costs. A Feasibility and Satisfaction Study.
9. Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study
10. The Relevance and Added Value of Geriatric Medicine (GM): Introducing GM to Non-Geriatricians
11. CureCancer Digital Platform In The Routine Clinical Oncology Practice Facilitates Patients’ Self-Data Recording, Communicating With Health Care Professionals, Treatment Adherence And “Distancing Interventions” During Covid-19 And Reduces Costs. A Feasibility And Satisfaction Study*.
12. Advanced Non–Small-Cell Lung Cancer in the Elderly
13. The Relevance and Added Value of Geriatric Medicine (GM): Introducing GM to Non-Geriatricians
14. Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
15. Malignant Transformation of Schneiderian Papilloma Presenting With Progressive Binocular Diplopia and Blepharoptosis
16. Propranolol and Weekly Paclitaxel in the Treatment of Metastatic Heart Angiosarcoma
17. Tyrosine Kinase Inhibitors (TKIs) for the Treatment of Concurrent Colorectal and Renal Cell Carcinomas
18. Pemetrexed Versus Erlotinib in Pretreated Patients With Advanced Non–Small Cell Lung Cancer: A Hellenic Oncology Research Group (HORG) Randomized Phase 3 Study
19. Docetaxel Versus Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
20. Malignant Transformation of Schneiderian Papilloma Presenting With Progressive Binocular Diplopia and Blepharoptosis
21. Screening of colorectal cancer (CRC) patients for lynch syndrome (LS) emphasizes the need for public insurance coverage of genetic testing: Results of a national program by the Hellenic Society of Medical Oncology (HeSMO).
22. Implications of KRAS status in first line chemotherapy with bevacizumab in advanced colorectal cancer: A phase IV study of Hellenic Oncology Research Group (HORG).
23. Phase II trial of modified FOLIRI plus Panitumumab as first-line treatment in elderly patients with RAS wild-type metastatic colorectal cancer.
24. Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
25. Phase II Trial of Mfoliri Plus Bevacizumab as 1st Line Treatment in Elderly Patients with Metastatic Colorectal Cancer
26. Phase I Trial of Panitumumab in Combination with Cisplatin, Fluourouracil and Docetaxel (Mdcf) in Advanced/Metastatic Gastric Cancer
27. Elderly and younger patients with non-small cell lung cancer (NSCLC) derive similar benefit from second-line chemotherapy: A retrospective subset analysis of second-line chemotherapy trials conducted from the Hellenic Cooperative Research Group (HORG).
28. Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
29. Non-Platinum-Based First-Line Followed by Platinum-Based Second-Line Chemotherapy or the Reverse Sequence in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis by the Lung Cancer Group of the Hellenic Oncology Research Group
30. A Dose Escalation Study of the Biweekly Administration of Paclitaxel, Oxaliplatin and Capecitabine in Patients with Advanced Solid Tumors
31. P-0279PHASE II TRIAL OF MFOLIRI PLUS BEVACIZUMAB AS 1ST LINE TREATMENT IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER.
32. P-0110PHASE I TRIAL OF PANITUMUMAB IN COMBINATION WITH CISPLATIN, FLUOUROURACIL AND DOCETAXEL (MDCF) IN ADVANCED/METASTATIC GASTRIC CANCER.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.